Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD

• Status: Completed
• Trial end date: 2015-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary goal of the study is to evaluate the use of a new smart phone application in preventing relapse to smoking among people with PTSD. The technology intervention will combine a mobile system to reward non-smoking, smoking cessation counseling, smoking cessation medications, and use of the smart phone app. The primary aim is to evaluate how effective this intervention is in preventing smoking relapse compared to another intervention that does not include the app.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Duke University
• Treatments: Bupropion; Nicotine

Criteria

Inclusion Criteria:

1. Meets criteria for current PTSD;

2. Has current smoking status of at least 10 cigarettes per day (verified with breath carbon monoxide measurement);

3. Has been smoking for at least 1 year;

4. Is aged 18 to 70;

5. Can speak and write current fluent conversation English; and

6. Is willing to make a smoking cessation attempt.

Exclusion Criteria:

1. Is pregnant;

2. Has diagnosis, based on DSM-IV criteria, of schizophrenia, schizophreniform disorder, schizoaffective disorder, current psychotic symptoms, delusional disorder, current (not in remission) substance use disorder, and/or current manic episode;

3. Will not be stable on medications for the study period;

4. Has history of myocardial infarction in past 6 months;

5. Uses any other forms of nicotine such as cigars, pipes, or chewing tobacco with unwillingness to stop use during study period; or

6. Is currently imprisoned.

7. Note: Participants may be excluded or asked to refrain from taking certain study medications if they have a seizure disorder, uncontrolled diabetes, an eating disorder, or current or past cirrhosis or hepatitis.